SEC
Whistleblower
Attorneys

July 02, 2020

Alexion Pharmaceuticals Inc.

FCPA

SANCTION AMOUNT: $21476531

Defendants: Alexion Pharmaceuticals Inc.

Respondent agreed to settle charges that it violated the books and records and internal controls provisions of the Foreign Corrupt Practices Act, based on payments to government officials over roughly a 5-year span by Turkish and Russian subsidiaries to secure favorable treatment for Respondent’s primary drug, Soliris.

Named one of the top whistleblower practices/attorneys in the country by The New York Times, Wall Street Journal and NPR
Thank you for submitting some email to us.